Sang Yi - 14 Feb 2025 Form 4 Insider Report for ZIMMER BIOMET HOLDINGS, INC. (ZBH)

Role
Group President, Asia Pacific
Signature
/s/ Matthew R. St. Louis, Attorney-in-Fact for Sang Yi (power of attorney previously filed)
Issuer symbol
ZBH
Transactions as of
14 Feb 2025
Net transactions value
$0
Form type
4
Filing time
19 Feb 2025, 18:03:29 UTC
Previous filing
04 Jun 2024
Next filing
24 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZBH Common Stock Options Exercise $0 +11,138 +201% $0.000000 16,676 18 Feb 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZBH Restricted Stock Units Award $0 +11,138 $0.000000 11,138 14 Feb 2025 Common Stock 11,138 Direct F2, F3
transaction ZBH Restricted Stock Units Options Exercise $0 -11,138 -100% $0.000000 0 18 Feb 2025 Common Stock 11,138 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 216 shares acquired under the Employee Stock Purchase Plan and pursuant to dividend reinvestment through February 18, 2025.
F2 Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Zimmer Biomet Holdings, Inc. (the "Company").
F3 On February 18, 2022, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2022 - 2024. As determined on February 14, 2025, based on actual performance, the reporting person earned 11,138 RSUs, which vested on February 18, 2025